Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Northwest Biotherapeutics (NWBO) Leases: 2019-2025

Historic Leases for Northwest Biotherapeutics (NWBO) over the last 7 years, with Sep 2025 value amounting to $4.3 million.

  • Northwest Biotherapeutics' Leases fell 4.76% to $4.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 million, marking a year-over-year decrease of 4.76%. This contributed to the annual value of $4.2 million for FY2024, which is 0.10% up from last year.
  • Latest data reveals that Northwest Biotherapeutics reported Leases of $4.3 million as of Q3 2025, which was down 2.69% from $4.4 million recorded in Q2 2025.
  • Over the past 5 years, Northwest Biotherapeutics' Leases peaked at $5.1 million during Q1 2021, and registered a low of $4.0 million during Q3 2022.
  • Its 3-year average for Leases is $4.2 million, with a median of $4.2 million in 2023.
  • As far as peak fluctuations go, Northwest Biotherapeutics' Leases rose by 20.56% in 2021, and later fell by 18.85% in 2022.
  • Quarterly analysis of 5 years shows Northwest Biotherapeutics' Leases stood at $4.9 million in 2021, then fell by 14.32% to $4.2 million in 2022, then declined by 0.14% to $4.2 million in 2023, then climbed by 0.10% to $4.2 million in 2024, then decreased by 4.76% to $4.3 million in 2025.
  • Its Leases stands at $4.3 million for Q3 2025, versus $4.4 million for Q2 2025 and $4.2 million for Q1 2025.